National Cancer Institute   U.S. National Institutes of Health | www.cancer.gov
US National Institute of Health www.cancer.gov
BCSC
Breast Cancer Surveillance Consortium: Working together to advance breast cancer research
 
Home   |   Data & Statistics   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Benchmarks for Abnormal Screening Mammography Interpretations from 2002 - 2006 --- based on BCSC data as of 2009*

You are viewing the 2009 collection of this data. Data from other times are also available:
  All Screening Examinations
Recall rate (RR) 9.7%
Readers with 1000+ examinations 370
Abnormal initial interpretations 185,139
All examinations 1,899,060
RR (Median - 50th percentile) 9.2
RR (25th, 75th percentiles) 6.1, 13.0
RR (10th, 90th percentiles) 4.1, 16.5
PPV1§ 4.2%
Readers with 100+ abnormal interpretations 364
Cancers 7,846
Abnormal initial interpretations 186,692
PPV1 (Median - 50th percentile) 4.2
PPV1 (25th, 75th percentiles) 2.9, 5.6
PPV1 (10th, 90th percentiles) 1.9, 7.4
PPV2|| 23.3%
Readers with 30+ biopsy recommended 226
Cancers 5,275
Abnormal final interpretations 22,609
PPV2 (Median - 50th percentile) 22.9
PPV2 (25th, 75th percentiles) 16.7, 30.8
PPV2 (10th, 90th percentiles) 12.0, 36.8
PPV3# 27.2%
Readers with 30+ biopsy performed 166
Cancers 4,335
Abnormal final interpretations, with known biopsy 15,962
PPV3 (Median - 50th percentile) 26.9
PPV3 (25th, 75th percentiles) 19.6, 35.2
PPV3 (10th, 90th percentiles) 15.3, 42.2

Notes

Numbers are frequencies unless otherwise indicated.

* Includes examinations for radiologists with minimum numbers of cases in a given row as designated; excludes examinations for which the radiologist is unknown.

Recall rate = the percentage of examinations with an abnormal initial interpretation (BI-RADS category 4, 5, or 0 -- category 3 with a recommendation for immediate follow-up was recoded as 0).

§ PPV1 = The percentage of examinations with an abnormal initial interpretation that result in a tissue diagnosis of cancer within 1 year.

|| PPV2 = The percentage of examinations with an abnormal final interpretation** that result in a tissue diagnosis of cancer within 1 year.

# PPV3 = the percentage of examinations with an abnormal final interpretation**, where it is known that a biopsy was performed as a result of the abnormal diagnostic examination, that result in a tissue diagnosis of cancer within 1 year.

** Abnormal final interpretation = BI-RADS category 4 or 5 -- categories 0 and 3 with a recommendation for biopsy were recoded as 4).

Table numbers last updated December 27, 2009. The following source must be cited when reproducing this table: NCI-funded Breast Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded xx/xx/xxxx from the Breast Cancer Surveillance Consortium Web site - http://breastscreening.cancer.gov/data/benchmarks/screening/2009/table5.html .

[Return to Performance Benchmarks for Screening Mammography]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences